Universitätsklinikum Carl Gustav Carus Dresden

Functional outcome, five-year survival and burden of disease after size- and location-matched hemorrhagic versus ischemic stroke (2026) Balk S, Siller T, Sprügel M, Haupenthal D, Kölbl K, Hock S, Heinze D, et al. Journal article Clinical and treatment-related predictors of complete response after total neoadjuvant therapy for rectal cancer in a large multicenter analysis (2026) Wurschi GW, Schneider M, Becker JN, Frerker B, Vorbach SM, Ehret F, Diefenhardt M, et al. Journal article A longitudinal bifactor approach to modelling somatic symptom development in psychosomatic treatment (2026) Petzke TM, Köteles F, Kessler H, Doering S, Kehyayan A, Pape M, Hofmann T, et al. Journal article Treatment patterns in geriatric patients with melanoma and the effect of age on the efficacy of immunotherapy: Analysis from the real-world multicenter registry ADOREG (2026) Lallas K, Nanz L, Ugurel S, Mohr P, Meier F, Weichenthal M, von Wasielewski I, et al. Journal article Attention decoding at the cocktail party: Preserved in hearing aid users, reduced in cochlear implant users (2026) Jehn C, Riegel J, Reichenbach T, Hahne A, Vavatzanidis NK Journal article PRDM16 expression is an independent prognostic factor in AML with the double-mutant NPM1/FLT3-ITD genotype (2026) Stasik S, Eckardt JN, Röllig C, Baldus CD, Serve H, Müller-Tidow C, Schäfer-Eckart K, et al. Journal article Diagnosis and Therapy of EndometriosisGuideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/045, April 2025) Diagnostik und Therapie der Endometriose. Leitlinie der DGGG, OEGGG und SGGG (S2k-Level, AWMF-Registernummer 015/045, April 2025) (2026) Burghaus S, Schäfer SD, Bär KJ, Bartley J, Beckmann M, Behrens A, Beyer K, et al. Journal article Characteristics and quality of life of nine-year survivors with metastatic melanoma treated with pembrolizumab beyond second-line therapy (2026) Dugas-Breit S, Forschner A, Erdmann M, Gutzmer R, Kähler KC, Holst I, Brekner A, et al. Journal article Randomized Comparison of Cardiotoxicity With 60 Versus 90 mg Daunorubicin in AML Induction Therapy (2026) Dendorfer SM, Schmidt-Brücken K, Kramer M, Steffen B, Schliemann C, Mikesch JH, Alakel N, et al. Journal article High pretreatment peripheral blood T-cell receptor clonality as a predictor of prolonged response in immune thrombocytopenia to the British Journal of Haematology (2026) Schmidt-Barbo P, Schultheiss C, Jauch AJ, Simnica D, Silling G, Hänel M, Chromik J, et al. Journal article